409 related articles for article (PubMed ID: 26558630)
1. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
[TBL] [Abstract][Full Text] [Related]
2. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
Wang D; Liu X; Liu Y; Li S; Wang C
J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
Zhou Q; Wang M; Du Y; Zhang W; Bai M; Zhang Z; Li Z; Miao J
Ann Neurol; 2015 Apr; 77(4):637-54. PubMed ID: 25611954
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Khan N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1740-1750. PubMed ID: 32542833
[TBL] [Abstract][Full Text] [Related]
7. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
8. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms.
Du Y; Qu J; Zhang W; Bai M; Zhou Q; Zhang Z; Li Z; Miao J
Neuropharmacology; 2016 Sep; 108():1-13. PubMed ID: 27067919
[TBL] [Abstract][Full Text] [Related]
9. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
[TBL] [Abstract][Full Text] [Related]
10. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
12. Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice.
Metaxas A; Vaitheeswaran R; Jensen KT; Thygesen C; Ilkjaer L; Darvesh S; Finsen B
Curr Alzheimer Res; 2018 Mar; 15(5):420-428. PubMed ID: 28982335
[TBL] [Abstract][Full Text] [Related]
13. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
[TBL] [Abstract][Full Text] [Related]
14. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
15. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.
Oyegbami O; Collins HM; Pardon MC; Ebling FJP; Heery DM; Moran PM
Curr Alzheimer Res; 2017; 14(8):850-860. PubMed ID: 28317486
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
[TBL] [Abstract][Full Text] [Related]
17. Z-Guggulsterone attenuates cognitive defects and decreases neuroinflammation in APPswe/PS1dE9 mice through inhibiting the TLR4 signaling pathway.
Liu J; Lin Y; Yang Y; Guo Y; Shang Y; Zhou B; Liu T; Fan J; Wei C
Biochem Pharmacol; 2022 Aug; 202():115149. PubMed ID: 35714682
[TBL] [Abstract][Full Text] [Related]
18. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L
Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651
[TBL] [Abstract][Full Text] [Related]
19. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
20. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
